A Clinical Trial is Seeking Volunteers with Breast Cancer or Lung Cancer
Researchers are evaluating an investigational drug to determine its safety and efficacy and test its impact on the tumors associated with non-small cell lung cancer and triple-negative breast cancer.
For those who have been diagnosed with lung cancer or breast cancer, this clinical trial may be an option. If you’d like to learn more, answer a few questions to see if you qualify.
Check eligibility
Study details
Participants must:
- Be 18 years of age or older
- Be diagnosed with one of the following:
- breast cancer
- lung cancer
- ovarian cancer (including fallopian tube and peritoneal cancer)
- endometrial cancer (including endometrioid and high grade serous)
- Have gone through cancer treatment
Participants must not:
- have prior ROR1 therapies or adoptive T-cell therapy
- have untreated or active infections
- have active untreated brain metastases
If you would like to speak to someone regarding this trial, first check to see if you are initially eligible through the prescreener above. If it seems that you are eligible to take part, you will be contacted by phone so we can ask you additional questions to confirm your eligibility, and you will be able to ask any questions you may have about this clinical trial. If you are not eligible based on your responses to the prescreener, you can always contact us at patientsupport@antidote.me to discuss further.